Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
Brand-name medications (Wegovy, Ozempic, Mounjaro, Zepbound, and Foundayo) carry a separate $25/month treatment plan fee on top of the medication cost
Recognizing Signs Your Semaglutide May No Longer Be Viable Inspect your semaglutide solution before every injection
Semaglutide represents a breakthrough in weight loss medications